HEU Community Logo
StartseiteFörderüberblick
Registrieren
Registrieren
Registrieren

ProjektkooperationAktualisiert am 19. Februar 2025

Next generation drug screening for precision oncology

Leen Assil Companioni

Public Funding Specialist bei CBmed GmbH

Graz, Österreich

Details

CBmed is developing an innovative quality-assured workflow to test the effect of drugs on patient-derived tumor cell with a particular interest on ovarian cancer and glioblastoma. This method can furnish a personalized medicine approach as the individual patient response to drugs can be established. Furthermore, combining these readouts with other -omics data can provide unprecedented access to precision oncology.

We are currently interested in identifying partners (especially from industry and ELSA) who would be interested in developing this project with us for submission to a 2023 2-stage call (HORIZON-HLTH-2024-TOOL-05-06-twostage: Innovative non-animal human-based tools and strategies for biomedical research)

Phase

  • Early - project idea
  • Planning

Typ

  • Citizen engagement
  • National, regional, local authority
  • Basic research
  • Applied research
  • Other
  • Standardisation
  • Policy
  • Producer, Manfacturer, Software Developer

Ähnliche Einträge